Jenna S. Hynes

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?”.

17-hydroxyprogesterone caproate for women with congenital uterine anomalies: does it impact the risk of recurrent preterm birth?

American Journal of Obstetrics & Gynecology MFM(2020)10.1016/j.ajogmf.2020.100278

N/A

0DataRank · unranked

0 citations

Amanda Schwartz, Azza Abdalla, Tracy A. Manuck, Sarah K. Dotters‐Katz, Jenna S. Hynes

Rates of preterm birth in multiparous women with congenital uterine anomalies

American Journal of Obstetrics & Gynecology MFM(2021)10.1016/j.ajogmf.2021.100392

N/A

0DataRank · unranked

3 citations

Amanda Schwartz, Sarahn M. Wheeler, Tracy A. Manuck, Sarah K. Dotters‐Katz, Jenna S. Hynes

Body mass index is negatively associated with a good perinatal outcome after in vitro fertilization among patients with polycystic ovary syndrome: a national study

F&S Reports(2022)10.1016/j.xfre.2022.11.014

N/A

0DataRank · unranked

10 citations

Jeremy M. Weber, Tracy Truong, Kelly S. Acharya, Jennifer L. Eaton, Jenna S. Hynes

IS THERE A BENEFIT TO EUPLOID DOUBLE EMBRYO TRANSFER IN PATIENTS WITH A HISTORY OF AT LEAST 1 FAILED SET?

Fertility and Sterility(2023)10.1016/j.fertnstert.2023.08.508

N/A

0DataRank · unranked

0 citations

Jenna S. Hynes, Michelle Kappy, Serin Seckin, Eric J. Forman, Evan A. Reshef